Sentences with phrase «new regenerative medicine research»

He was actively involved in the planning and construction of the Institute's new Regenerative Medicine Research Center which opened last April.

July 2010 - Urban Lendahl Heads New Research Centre EuroSyStem PI Urban Lendahl named as Scientific Director of the Wallenberg Institute for Regenerative Medicine EuroSyStem PI Urban Lendahl will be the Scientific Director of a new regenerative medicine research centre at the Karolinska Instituet in Stockholm.

Not exact matches

The new tower will also host the Medicine by Design initiative, set to become a leading centre in regenerative medicine at the University of Toronto with the federal government committing $ 114 - million for this project through the Canada First Research ExcellenMedicine by Design initiative, set to become a leading centre in regenerative medicine at the University of Toronto with the federal government committing $ 114 - million for this project through the Canada First Research Excellenmedicine at the University of Toronto with the federal government committing $ 114 - million for this project through the Canada First Research Excellence Fund.

In a groundbreaking study that provides scientists with a critical new understanding of stem cell development and its role in disease, UCLA researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research led by Dr. Kathrin Plath, professor of biological chemistry, have established a first - of - its - kind methodology that defines the unique stages by which specialized cells are reprogrammed into stem cells that resemble those found in the embryo.

«Despite new therapies, it's virtually inevitable that a patient with multiple myeloma will experience relapse of the disease at some point,» said senior author Catriona Jamieson, MD, PhD, professor of medicine, Koman Family Presidential Endowed Chair in Cancer Research and chief of the Division of Regenerative Medicine at UC San Diego School of Mmedicine, Koman Family Presidential Endowed Chair in Cancer Research and chief of the Division of Regenerative Medicine at UC San Diego School of MMedicine at UC San Diego School of MedicineMedicine.

This work provides us with a promising new tool in the CRISPR toolbox,» said author Dr. Eric Olson, Chairman of Molecular Biology, Co-Director of the UT Southwestern Wellstone Muscular Dystrophy Cooperative Research Center, and Director of the Hamon Center for Regenerative Science and Medicine.

Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and Center for Duchenne Muscular Dystrophy at UCLA have developed a new approach that could eventually be used to treat Duchenne muscular dystrophy.

Dr Stephen Simpson, director of research and programmes at Arthritis Research UK added: «This is exciting, novel work in the field of regenerative medicine, which although in its early experimental stages, could take us a step closer to our ultimate goal of a more effective and much - needed new treatment for the very many people who live with this painful joint conditionresearch and programmes at Arthritis Research UK added: «This is exciting, novel work in the field of regenerative medicine, which although in its early experimental stages, could take us a step closer to our ultimate goal of a more effective and much - needed new treatment for the very many people who live with this painful joint conditionResearch UK added: «This is exciting, novel work in the field of regenerative medicine, which although in its early experimental stages, could take us a step closer to our ultimate goal of a more effective and much - needed new treatment for the very many people who live with this painful joint condition.»

Applying a new method that is used mainly in stem - cell research and regenerative medicine, researchers from the Technical University of Munich have now devised a robust intestinal model for molecular research into incretin release in a test tube (in vitro).

Scientists from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research are bringing stem cell science funded by the California Institute of Regenerative Medicine (CIRM), the state stem cell agency, directly to patients in two exciting new clinical trials scheduled to begin in early 2014.

A team of scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) discovered a new bone - forming growth factor, Osteolectin (Clec11a), which reverses osteoporosis in mice and has implications for regenerative medicine.

FORT LAUDERDALE / DAVIE, Fla. — Leading faculty members from the Nova Southeastern University (NSU) College of Allopathic Medicine (M.D. College) are scheduled to present their research related to advancing new approaches to cancer immunotherapy and regenerative medicine at the 2018 World Stem Cell SummitMedicine (M.D. College) are scheduled to present their research related to advancing new approaches to cancer immunotherapy and regenerative medicine at the 2018 World Stem Cell Summitmedicine at the 2018 World Stem Cell Summit (WSCS).

Co-organizers are the Regenerative Medicine Foundation, Karolinska Institute, Maryland Stem Cell Research Fund / TEDCO, Mayo Clinic, The New York Stem Cell Foundation, Nova Southeastern University and NSU Cell Therapy Institute, The Cure Alliance, Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine, University of Florida Center for Regenerative Medicine, Wake Forest Institute for Regenerative Medicine, and Weill Cornell Medicine.

New research by scientists at the Pennsylvania Cancer and Regenerative Medicine Research Center, a division of the Baruch S. Blumberg Institute, shows that medicines currently used in HIV treatment may help to target chemotherapy for breastresearch by scientists at the Pennsylvania Cancer and Regenerative Medicine Research Center, a division of the Baruch S. Blumberg Institute, shows that medicines currently used in HIV treatment may help to target chemotherapy for breastResearch Center, a division of the Baruch S. Blumberg Institute, shows that medicines currently used in HIV treatment may help to target chemotherapy for breast cancer.

Housed in NSU's Center for Collaborative Research, the NSU Cell Therapy Institute focuses on advancing new approaches to cancer immunotherapy and regenerative medicine

The study was supported by the California Institute for Regenerative Medicine, the National Institutes of Health (grants HL125040, GM007365, HL119553, HL071546, HL100405, NS069375, RR029338 and OD018220), the Howard Hughes Medical Institute, anonymous donors, the Agency for Science, Technology and Research in Singapore, the Siebel Stem Cell Institute, the Fannie and John Hertz Foundation, the National Science Foundation, the Davidson Institute for Talent Development, the Paul and Daisy Soros Fellowship for New Americans and the Alfred Sloan Foundation.

A new initiative combining breakthroughs in research, private sector support, and a non-profit committed to regenerative medicine is dedicated to improving this process.

Our research is located at the interface of immunology and stem cell research and our recent findings lay the groundwork for new cellular therapy approaches in regenerative medicine.

Under his direction, from 2003 to 2007, the agency brought a new level of commitment to public health, with special emphasis on emerging issues such as bioterrorism and emergency preparedness, as well as health disparities, patient safety and creation of the Illinois Regenerative Medicine Institute to support stem cell research.

In 2013, the California Institute for Regenerative Medicine (CIRM)-- the nation's largest funder of stem cell research outside of the federal government — authorized a new program, the Alpha Stem Cell Clinics Network.

With more than three decades of focused research and application, the Maharaj Institute is pioneering Immune Regenerative Medicine and breaking new ground in the pursuit of more effective treatment and prevention of illness.

«On a sure path to greatness,» as Dr. Allis described his former student, Dr. Wysocka has already accumulated an impressive number of awards and honors, in addition to the ISSCR accolade: the California Institute for Regenerative Medicine Basic Biology Awards (2011); W. M. Keck Distinguished Young Scholar in Medical Research Award (2008 — 2013); California Institute for Regenerative Medicine New Faculty Award (2008 — 2013); Searle Scholar Award (2007 — 2010); and Baxter Foundation Award (2007).

«This year we were honored to join forces with a new research partner and investor, W.L. Gore & Associates, and garner continued support from long - time investors, which includes new funding from both JDRF and the California Institute for Regenerative Medicine.

SAN FRANCISCO, CA — A new biopharmaceutical company, Tenaya Therapeutics Inc., will build on discoveries in cardiovascular disease research made at the Gladstone Institutes, concentrating on regenerative medicine and drug discovery for heart failure.

Alain Destexhe, Research Director of Unité de Neurosciences CNRS, Gif - sur - Yvette, France Bruno Weber, Professor of Multimodal Experimental Imaging, Universitaet Zuerich, Switzerland Carmen Gruber Traub, Fraunhofer, Germany Costas Kiparissides, Certh, Greece Cyril Poupon, Head of the Nuclear Magnetic Resonance Imaging and Spectroscopy unit of NeuroSpin, University Paris Saclay, Gif - sur - Yvette, France David Boas, Professor of Radiology at Massachusetts General Hospital, Harvard Medical School, University of Pennsylvania Hanchuan Peng, Associate Investigator at Allen Brain Institute, Seattle, US Huib Manswelder, Head of Department of Integrative Neurophysiology Center for Neurogenomics and Cognitive Research, VU University, Amsterdam Jan G. Bjaalie, Head of Neuroinformatics division, Institute of Basic Medical Sciences, University of Oslo, Norway Jean - François Mangin, Research Director Neuroimaging at CEA, Gif - sur - Yvette, France Jordi Mones, Institut de la Macula y la Retina, Barcelona, Spain Jurgen Popp, Scientific Director of the Leibniz Institute of Photonic Technology, Jena, Germany Katharina Zimmermann, Hochshule, Germany Katrin Amunts, Director of the Institute Structural and functional organisation of the brain, Forschungszentrum Juelich, Germany Leslie M. Loew, Professor at University of Connecticut Health Center, Connecticut, US Marc - Oliver Gewaltig, Section Manager of Neurorobotics, Simulation Neuroscience Division - Ecole Polytechnique fédérale de Lausanne (EPFL), Geneve, Switzerland Markus Axer, Head of Fiber architecture group, Institute of Neuroscience and Medicine (INM - 1) at Forschungszentrum Juelich, Germany Mickey Scheinowitz, Head of Regenerative Therapy Department of Biomedical Engineering and Neufeld Cardiac Research Institute, Tel - Aviv University, Israel Pablo Loza, Institute of Photonic Sciences, Castelldefels, Spain Patrick Hof, Mount Sinai Hospital, New York, US Paul Tiesinga, Professor at Faculty of Science, Radboud University, Nijmegen, Netherlands Silvestro Micera, Director of the Translational Neural Engineering (TNE) Laboratory, and Associate Professor at the EPFL School of Engineering and the Centre for Neuroprosthetics Timo Dicksheid, Group Leader of Big Data Analytics, Institute Structural and functional organisation of the brain, Forschungszentrum Juelich, Germany Trygve Leergaard, Professor of Neural Systems, Institute of Basic Medical Sciences, University of Oslo, Norway Viktor Jirsa, Director of the Institute de Neurosciences des Systèmes and Director of Research at the CNRS, Marseille, France

Acknowledgments We express sincere thanks to the following organizations that have contributed to the CASMI Translational Stem Cell Consortium (CTSCC) as funding and events partners, without whom the consortium and the benefits it will bring to stem cell translation would be constrained: GE Healthcare, the Center for Commercialization of Regenerative Medicine (CCRM), Sartorius Stedim Biotech (formerly TAP Biosystems), Lonza, the California Institute for Regenerative Medicine (CIRM), the Strategies for Engineered Negligible Senescence (SENS) Research Foundation, UK Cell Therapy Catapult, NIH Centre for Regenerative Medicine, the New York Stem Cell Foundation (NYSCF), ThermoFisher Scientific, Eisai, Medipost (US), Medipost (Korea), Celgene, Roche and Oxford Biomedica.

Acknowledgments We express sincere thanks to the following organizations that have contributed to the CASMI Translational Stem Cell Consortium (CTSCC) as funding and events partners, without whom the consortium and the benefits it will bring to stem cell translation would be constrained: GE Healthcare, the Center for Commercialization of Regenerative Medicine (CCRM), Sartorius Stedim Biotech (formerly TAP Biosystems), Lonza, the California Institute for Regenerative Medicine (CIRM), the Strategies for Engineered Negligible Senescence (SENS) Research Foundation, UK Cell Therapy Catapult, NIH Centre for Regenerative Medicine, the New York Stem Cell Foundation (NYSCF), ThermoFisher Scientific, Eisai, Medipost (US), Medipost (Korea), Celgene, Roche and Oxford BioMedica (UK) Ltd..

UCSB will get more than $ 500,000 for tools and technologies to develop new treatments for diseases that can be helped by stem cell research, thanks to a grant from the California Institute for Regenerative Medicine.

«We have a great deal of admiration and respect for Dr. Baltimore and Dr. Witte, and this new center brings together some of the brightest minds in science and medicine,» says Eli Broad, founder of The Eli and Edythe Broad Foundation and a major funder of the Broad Center for the Biological Sciences at Caltech, the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at the University of California, San Francisco, and the Broad Institute for Biomedical Research in partnership with Harvard medicine,» says Eli Broad, founder of The Eli and Edythe Broad Foundation and a major funder of the Broad Center for the Biological Sciences at Caltech, the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at the University of California, San Francisco, and the Broad Institute for Biomedical Research in partnership with Harvard Medicine and Stem Cell Research at UCLA, the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at the University of California, San Francisco, and the Broad Institute for Biomedical Research in partnership with Harvard Medicine and Stem Cell Research at USC, the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at the University of California, San Francisco, and the Broad Institute for Biomedical Research in partnership with Harvard Medicine and Stem Cell Research at the University of California, San Francisco, and the Broad Institute for Biomedical Research in partnership with Harvard and MIT.

It continues to the present with her newest projects, among which is the Infinity Engine, a functioning genetics laboratory that proposes possible scenarios for the future of life on Earth, not «sci - fi,» as Hershman Leeson puts it, but «sci - tru,» based on biogenetic research, artificial intelligence, cloning, mutations, transgenic experiments and regenerative medicine.